FDA-Cleared CGM Device Supply & Logistics

The contract pertains to the supply and logistics management of Dexcom Stelo biosensors, which are FDA-cleared wearable continuous glucose monitoring (CGM) devices integrated into the Signos platform. This subcontract requires the successful bidder to ensure consistent, reliable delivery of these medical devices to support platform operations, adhering to stringent regulatory and quality standards commensurate with FDA-cleared healthcare products. The scope encompasses end-to-end logistics including inventory management, warehousing, distribution, and compliance with all applicable medical device handling and tracking protocols to maintain product integrity and regulatory compliance throughout the supply chain. The opportunity is posted under the Department of Veterans Affairs’ 261-NETWORK Contract Office 21 (36C261) with a NAICS code of 339112, indicating classification within the medical equipment and supplies manufacturing sector. Responses are due by August 3, 2026, with no set-aside provisions specified, making it open to all eligible contractors. Performance is expected to support federal healthcare delivery systems through seamless integration of the CGM devices into the Signos platform, though no specific performance location is provided. Bidders must demonstrate capability in handling regulated medical devices at scale, with proven experience in logistics for FDA-cleared wearables and alignment with federal healthcare supply chain requirements.